Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Stringent doxycycline dependent control of CRE recombinase in vivo.

Nucleic acids research | Dec 1, 2002

http://www.ncbi.nlm.nih.gov/pubmed/12466566

The strategy of modulating gene activities in vivo via CRE/loxP recombination would greatly profit from subjecting the recombination event to an independent and stringent temporal control. Here, we describe a transgenic mouse line, LC-1, where the expression of the cre and luciferase gene is tightly controlled by the Tet system. Using the R26R mouse line as indicator for CRE activity, and mouse lines expressing tetracycline controlled transactivators (tTA/rtTA) in various tissues, we show that; (i) in the non-induced state CRE recombinase is tightly controlled throughout the development and adulthood of an animal; (ii) upon induction, efficient recombination occurs in the adult animal in all tissues where tTA/rtTA is present, including hepatocytes, kidney cells, neurons and T lymphocytes; and (iii) no position effect appears to be caused by the LC-1 locus. Moreover, using the novel rTA(LAP)-1 mouse line, we show that in hepatocytes, complete deletion of the loxP-flanked insert in R26R animals is achieved less than 48 h after induction. Thus, the LC-1 mouse appears suitable for exploiting two rapidly increasing collections of mouse lines of which one provides tTA/rtTA in specific cell types/tissues, and the other a variety of loxP-flanked genes.

Pubmed ID: 12466566 RIS Download

Mesh terms: Animals | Anti-Bacterial Agents | CCAAT-Enhancer-Binding Protein-beta | Doxycycline | Gene Expression Regulation | Integrases | Luciferases | Mice | Mice, Inbred BALB C | Mice, Inbred C57BL | Mice, Transgenic | Promoter Regions, Genetic | Trans-Activators | Transcription, Genetic | Viral Proteins